From James Beck, Ph.D., Director of Research Programs This blog is part two in a series of three about the BigBrain. Several weeks ago saw the announcement of a description of a new and highly detailed atlas of the brain, called BigBrain. PDF wrote about how one person, making the decision to donate their brain, has made a significant contribution to science. Indeed, that is true. But what does this really mean for the future of neuroscience … and Parkinson’s research?
Articles by this Author:
From James Beck, Ph.D., Director of Research Programs Should or could a human gene be patented? On June 13th, the Supreme Court of the United States delivered their unanimous ruling regarding what has been called the Myraid Genetics case. The plaintiffs in this case sought to invalidate Myriad’s patent on two genes that when mutated can lead to a significant increased risk of breast and ovarian cancers. Because of the patent for these two genes, Myriad, a clinical diagnostic testing company, was the only entity that was permitted to perform the clinical tests that can both inform women if they… Read More
From James Beck, Ph.D., Director of Research Programs A recent paper published in the American Journal of Clinical Nutrition and picked up by the popular press provided some provocative evidence that vitamin D may provide a short term benefit to some people living with Parkinson’s disease. PDF has covered the science regarding vitamin D for some time, for example in articles featured here and here. While the importance of vitamin D in people with PD is not new—most people with PD have too low a level—this paper now suggests that only some individuals may benefit from raising vitamin D levels…. Read More
From James Beck, Ph.D., Director of Research Programs The genetic testing company 23andMe recently announced that it had reached its goal of enrolling 10,000 people with Parkinson’s into its genetic testing program. I personally think that is fabulous. While genetic abnormalities that lead to Parkinson’s disease are rare, finding these cases has been a boon to understanding PD for all. From the location and then discovery of the first PD gene by PDF’s first supported fellow, Roger Duvoisin, M.D., and his colleagues in 1996 to the more recent genetic discoveries of today, PDF steadfastly supports research into understanding how genetics and… Read More
From James Beck, Ph.D., Director of Research Programs Recently, former President George H.W. Bush revealed in an interview with PARADE Magazine that he has vascular parkinsonism. While not meeting the criteria for true Parkinson’s disease (PD), vascular parkinsonism mimics many features of PD. As its name implies, vascular parkinsonism is often due to problems with the vessels in the brain regions that control movement and small strokes are the primary cause. Although small strokes will cumulatively worsen the symptoms of vascular parkinsonism, it is otherwise not considered a progressive neurodegenerative disease like PD. People with vascular parkinsonism often experience a “lower… Read More
Today is a big day for many at PDF — it is our annual grant review. Of course, those most affected by what goes on in the big conference room will not be there. There are two groups who depend on tomorrow’s outcome: the scientists who have given us their best ideas for our scientific advisors to judge and the people who live every day with Parkinson’s and are counting on these great ideas to make a difference in their disease and their lives. I am confident that the team of scientists helping — members of our scientific advisory board… Read More